Clinical Trial Update: Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims

View source ↗

Summary

A completed study that emulates the SUSTAIN6 type 2 diabetes trial using healthcare claims to evaluate outcomes with semaglutide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED